VVantive provides therapies and services for vital organ care, with a focus on kidney care and dialysis. Its offerings include dialysis therapies, digital solutions, and support services designed to streamline administration for care teams and fit more easily into providers’ workflows and patients’ lives. The company differentiates itself through a long, 70-year track record, a global reach, and an integrated approach that combines devices, digital tools, and services to deliver more flexible, efficient care. Its goal is to extend patients’ lives by improving the dialysis experience and advancing broader vital organ therapies, making treatment easier to integrate into daily life and clinical practice.
Work here?Claim your company
Industries
Company Size
5,001-10,000
Company Stage
Acquired
Total Funding
N/A
Headquarters
Redwood City, CA
Founded
1990
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
N/A
N/A
Industry Average
Funded Over
1 Rounds
Rockwell Medical will buy Vantive's hemodialysis business for a base price of $125 million, the Michigan-based company announced on November 3, 2026. The deal covers concentrates, machines, water treatment systems, consumables and technical services. It also includes Vantive's one million square foot manufacturing campus in Medolla, Italy. Rockwell estimates the combined business could generate annual revenue of $400 million to $450 million. Vantive is financing the price through two $50 million term loans and a $25 million convertible note. It may also receive up to $45 million more, based on revenue and EBITDA milestones. The deal is expected to close in mid-2027, pending regulatory approvals. Rockwell has withdrawn its 2026 guidance because of expected deal and financing costs.
Vantive announces agreement to divest majority of hemodialysis assets and associated operations to Rockwell Medical. Nov 03, 2026, 06:01 ET Sharpens Vantive's Focus on Home Dialysis and Critical Care DEERFIELD, Ill., Nov. 3, 2026 /CNW/ - Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced that it has entered into a definitive agreement with Rockwell Medical, Inc. (Nasdaq: RMTI) to divest the majority of the assets and associated operations related to Vantive's hemodialysis (HD) business. This transaction advances Vantive's evolution, with a more focused, growth-oriented portfolio centered around chronic disease management and critical care intervention. Vantive is building on its legacy of innovation by prioritizing investment in the areas where it is uniquely positioned to make a meaningful difference for patients and care teams. Throughout its history, Vantive has pioneered therapies that redefined kidney care - from making home dialysis broadly available to patients living with chronic kidney disease, to advancing continuous renal replacement therapy for patients experiencing acute kidney injury in the intensive care unit (ICU). Today, Vantive is making dialysis easier to start, manage and sustain by enabling more patients to receive therapy at home, while selectively expanding its kidney care platform to advance a more integrated approach to addressing organ failure in the ICU setting. "We see a significant opportunity to close the gap between the care we know is possible and the care patients and providers experience today," said Chris Toth, CEO of Vantive. "This announcement brings Vantive's ambition into sharper focus. We are applying our expertise and scale to make care easier to access, simpler to deliver and more effective for the people who rely on our therapies. Whether that care happens at home over many years or in the ICU during a critical moment, our goal is to help ensure the right therapy can be delivered at the right time, with greater confidence for care teams." Positioning HD for Continued Growth with Rockwell Medical Under the terms of the agreement, Rockwell Medical will acquire Vantive's hemodialysis concentrates, HD monitors, and water treatment systems, together with related consumables and technical services. Toth continued, "We are confident Rockwell Medical is well positioned to support the continued growth and development of this important therapy. With a singular focus on hemodialysis, Rockwell Medical is deeply committed to accelerating the progress that our team has made. As a result, we believe the combined business will benefit from increased investment, creating new opportunities for innovation and growth. We are committed to working together through the transition to help ensure continuity of care and reliable access to the products, services and support that patients and care providers depend on." "This transaction represents an exciting opportunity to build on the strong foundation established by the Vantive team over many decades," said Mark Strobeck, Ph.D., President and CEO of Rockwell Medical. "As a company singularly focused on hemodialysis, we are committed to advancing the quality, reliability and customer support that providers and patients depend on every day. We believe this portfolio has significant opportunities for continued growth, and we look forward to bringing together complementary capabilities to better serve dialysis providers worldwide and further strengthen our position in the global hemodialysis market." The transaction is expected to close in mid-2027, subject to receipt of required regulatory approvals and satisfaction of other customary closing conditions. Upon the completion of the transaction, ownership of Vantive's manufacturing facility in Medolla, Italy will transfer to Rockwell Medical to support capacity and the continued development of the global HD business. Vantive's dialyzer portfolio, including the Theranova dialyzer, which enables HDx therapy (expanded hemodialysis), is not included in the transaction. Perella Weinberg Partners LP and Barclays are acting as financial advisors, and Kirkland & Ellis LLP is acting as legal counsel to Vantive. Aquilo Partners, L.P. is acting as exclusive financial advisor and Gibson Dunn & Crutcher LLP is acting as legal counsel to Rockwell Medical. Vantive, HDx, and Theranova are trademarks of Vantive Health LLC or its affiliates. About Vantive Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams globally. For 70 years, our team has driven meaningful innovations in kidney care. Today, Vantive's people, solutions and services deliver over 1 million touchpoints each day to patients around the world. As we build on our legacy, we are focused on elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. Our goal is to provide therapies that fit more easily into providers' practices and patients' lives. Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients- that is what Vantive aspires to deliver. To learn more, visit www.vantive.com and follow us on LinkedIn, X, Facebook, Instagram and YouTube. About Rockwell Medical Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient's home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work(R) four years in a row (2023-2026) and named Fortune Best Workplaces in Manufacturing & Production(TM) three years in a row (2024-2026), Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions(TM). For more information, visit www.rockwellmed.com. SOURCE VANTIVE US HEALTHCARE LLC Vantive, Michelle Therrien, [email protected]; Rockwell Medical, (248) 432-1362, [email protected]
Vantive to invest $100 million in Mountain Home factory, add 175 jobs. Vantive, a maker of products and digital platforms for kidney care and vital organ support, plans to invest $100 million over the next four years in an expansion of its factory in...
Vantive announces $100 million investment in Mountain Home, Arkansas facility. Vantive plans to expand operations, create 175 jobs over next four years. MOUNTAIN HOME, Ark., Oct. 27, 2026 (GLOBE NEWSWIRE) - Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, is announcing a new $100 million investment to expand its operations in Mountain Home, Arkansas, which will create hundreds of new jobs and modernize its facilities. The company plans to create up to 175 new jobs over the next four years, starting with 75 in the first year. This is an exciting milestone for Mountain Home, for Vantive, and for the patients we serve around the world. "This is an exciting milestone for Mountain Home, for Vantive, and for the patients we serve around the world," said Chris Toth, CEO of Vantive. "Our investment builds on our longstanding partnership with this community and reflects our confidence in the exceptional Mountain Home team. As demand for our therapies continues to grow, this expansion will increase our capacity, create new jobs, and help ensure that patients worldwide have access to the home dialysis products they rely on. The Mountain Home team plays a critical role in advancing our mission to extend lives and expand possibilities, and we are proud to continue growing our presence and employee base here in Arkansas." Vantive announced the new investment at the Mountain Home facility on Tuesday. Governor Sarah Huckabee Sanders, along with state and local officials, joined Vantive executives and team members to celebrate the announcement. "Vantive represents the kind of business we want as a cornerstone of Arkansas communities: one that improves patients' lives while investing in the people who drive its success," said Governor Sanders. "This investment is a leap forward in Vantive's commitment to advancing kidney care while simultaneously expanding opportunity for Arkansans and strengthening Mountain Home's workforce and economy for years to come." Vantive develops and delivers products and services focused on chronic disease management and critical care intervention. The company is working to make dialysis easier to start, manage and sustain by enabling more patients around the world to receive therapy at home, while expanding its kidney care platform to advance a more integrated approach to addressing organ failure in the intensive care unit (ICU) setting. The Mountain Home facility is a critical part of Vantive's global supply chain, serving as a key manufacturing site for essential components of home dialysis therapies used by patients around the world. Vantive currently has approximately 800 employees in Mountain Home. "When an industry leader like Vantive decides to invest in a community, it sends a message that they have confidence in that area - and with Vantive's $100 million investment, they are showing their confidence in Mountain Home, Arkansas," said Clint O'Neal, executive director of the Arkansas Economic Development Commission. "This is a huge moment for Vantive, which is growing this critical U.S. facility, and for the City of Mountain Home, and we congratulate them both on this milestone." The $100 million investment will be utilized for a range of capital expenditures for the Mountain Home site, including a new tubing line, new sterilizers, new compressors, a new chemistry lab, and other expansion projects. This investment builds upon a long-standing 60-year history in the Mountain Home facility, and adds to the $100 million in past investments that were made over the last few years and completed in 2025. "When I look at Vantive's expansion, I think about the 800 people already working here, the hundreds more who may have that opportunity, and the fact that a company helping patients receive life-sustaining dialysis at home is choosing to grow right here in Mountain Home," said Dr. Dani Autrey, President and CEO of the North Central Arkansas Economic Alliance." Vantive will be adding approximately 175 employees over four years, including 75 new employees expected to be added in the coming year. Employees will be hired for a range of high-skill, technical roles, including engineering. Additional information about future Vantive career opportunities in Mountain Home will be posted here as they become available. About Vantive Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams globally. For 70 years, our team has driven meaningful innovations in kidney care. Today, Vantive's people, solutions and services deliver over 1 million touchpoints each day to patients around the world. As we build on our legacy, we are focused on elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. Our goal is to provide therapies that fit more easily into providers' practices and patients' lives. Greater flexibility and efficiency in therapy administration for care teams, and longer, fuller lives for patients - that is what Vantive aspires to deliver. For more information, visit www.vantive.com and follow us on LinkedIn, X, Facebook, Instagram and YouTube. About the Arkansas Economic Development Commission At AEDC, we know economic advancement doesn't happen by accident. We work strategically with businesses and communities to create strong economic opportunities, making Arkansas the natural choice for success. AEDC is a division of the Arkansas Department of Commerce. To learn more, visit ArkansasEDC.com.
Vantive to invest $100 million in Mountain Home factory, add 175 jobs. 2 hours, 59 minutes ago by Hunter Myers Vantive, a maker of products and digital platforms for kidney care and vital organ support, plans to invest $100 million over the next four years in an expansion of its factory in Mountain Home that will create as many as 175 jobs. Vantive plans to add 75 jobs in the first year with more positions to be added over the next three years, the company said Tuesday. The new jobs include high-skill technical positions, such as engineering. Currently, the Mountain Home facility employs about 800 people. The investment will fund several improvement projects including a new tubing line, new sterilizers, new compressors, a new chemistry lab and other expansion projects, the company said in the announcement. The facility is a major manufacturing site in Vantive's global supply chain, producing several essential components for home dialysis therapies used by patients around the world. "This is an exciting milestone for Mountain Home, for Vantive, and for the patients we serve around the world," said Vantive Chief Executive Officer Chris Toth. Toth said the upcoming investment will build on the company's longstanding relationship with the community and reflects confidence in its Mountain Home employees. Gov. Sarah Huckabee Sanders joined company executives and state and local officials to announce the expansion plan at a news conference at the Mountain Home facility. She said the investment would create employment opportunities and strengthen the local workforce and economy. "Vantive represents the kind of business we want as a cornerstone of Arkansas communities: one that improves patients' lives while investing in the people who drive its success," Sanders said. Toth said the growing demand for Vantive's therapies is driving expansion, which is intended to increase production capacity and ensure patients have access to home dialysis products. The new investment comes after the completion of $100 million spent on additions to the factory over the last several years, which were completed in 2025. Clint O'Neal, executive director of the Arkansas Economic Development Commission, said the investment demonstrates the company's confidence in Mountain Home. "This is a huge moment for Vantive, which is growing this critical U.S. facility, and for the City of Mountain Home, and we congratulate them both on this milestone," O'Neal said.
Find jobs on Simplify and start your career today
We update Vantive's jobs every few hours, so check again soon!Browse all jobs
Industries
Company Size
5,001-10,000
Company Stage
Acquired
Total Funding
N/A
Headquarters
Redwood City, CA
Founded
1990
Find jobs on Simplify and start your career today
We update Vantive's jobs every few hours, so check again soon!Browse all jobs